Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
Add more filters










Database
Language
Publication year range
1.
Immunopharmacol Immunotoxicol ; 41(1): 123-129, 2019 Feb.
Article in English | MEDLINE | ID: mdl-30721634

ABSTRACT

Context: Fluconazole (FNZ) is a drug used in antifungal therapy. However, the minimum FNZ dose to interfering with immune responses or inducing DNA damage is still unknown. Objective: This study investigated the toxicological profile of FNZ on cultured human peripheral blood mononuclear cells (PBMCs) treated with different concentrations of this azole. Materials and methods: Cultured PBMCs were exposed to FNZ (6, 12, 30, 60 and 120 µg/mL) and the toxicological profile was assessed by the following parameters: cytotoxic and nuclear division index (necrotic, apoptotic and viable cells), DNA damage (alkaline comet test), mutagenic potential (micronucleus test), cytokine modulation (IL-1, IL-6, IL-10, TNF-α, IFN-γ), and predictive toxicity (Osiris® and LAZAR® programs). Results: Our results demonstrated that FNZ induced cellular DNA damage and mutagenicity at concentrations above the plasma peak (>30 µg/mL) and 6 µg/mL, respectively, which was associated with increased TNF-α, and decrease IL-6 and IL-10 concentrations. These effects may be related to increased apoptosis and cytotoxic nuclear division index in the cultured PBMCs. In silico results indicated potential mutagenic, tumorigenic, irritant, and carcinogenic effects, which were partially confirmed by the above assays. Discussion and conclusions: Together, these findings suggest the need to rationalize the use of FNZ, especially if it is used for long periods or with concomitant pathologies requiring azole therapy that may increase FNZ's plasma concentration.


Subject(s)
Antifungal Agents/toxicity , Cytokines/immunology , DNA Damage , Fluconazole/toxicity , Leukocytes, Mononuclear/drug effects , Mutagens/toxicity , Apoptosis/drug effects , Apoptosis/genetics , Cell Survival/drug effects , Cells, Cultured , Dose-Response Relationship, Drug , Humans , Interleukin-10/immunology , Interleukin-6/immunology , Leukocytes, Mononuclear/immunology , Leukocytes, Mononuclear/pathology , Tumor Necrosis Factor-alpha/immunology
2.
Exp Clin Endocrinol Diabetes ; 124(10): 597-601, 2016 Nov.
Article in English | MEDLINE | ID: mdl-27657999

ABSTRACT

Objectives: This study investigate the effects of a high intensity interval training (HIIT) and 2 weeks of detraining in functional and body composition parameters, lipoproteins, glucose metabolismand inflammation markers in postmenopausal women with metabolic syndrome (MS). Design: 17 untrained women with MS underwent a HIIT program for 12 weeks. Methods: The training was performed in treadmills, 3 days per week, with intensity ranging from 70-90% of the maximum heart rate (HRmax) and 2 weeks untrained (inactive). Functional and body composition parameters were evaluated before and after the training, while maximal oxygen uptake, lipoprotein and inflammation markers were analyzed before, after training and also in detraining. Results: The HITT program resulted in changesparameters as glucose, HbA1cand NOx after training. In addition, a reduction in pro-inflammatory interleukins and an increase in IL-10 after the HIIT program were found. However, an increase in plasma levels of lipoprotein was found and body composition parameters remain unaltered.Besides, only 2 weeks of detraining are able to revert the effects on inflammatory parameters afforded by the HIIT program. Conclusions: The HIIT program used here positively affected inflammatory profile and other parameters, as glucose, HbA1cand NOx, on postmenopausal women with MS. Moreover, 2 weeks of detraining can reverse the beneficial effects of HIIT program. Our results point out the necessity to aply acontinuous HITT program, in order maintain the benefits detected, to post menopausal women with MS.


Subject(s)
High-Intensity Interval Training/methods , Inflammation/blood , Inflammation/therapy , Interleukins/blood , Metabolic Syndrome/blood , Metabolic Syndrome/therapy , Blood Glucose/metabolism , Cytokines , Female , Glycated Hemoglobin/metabolism , Humans , Middle Aged
3.
Pharmacogenomics J ; 16(6): 501-506, 2016 11.
Article in English | MEDLINE | ID: mdl-26882122

ABSTRACT

Rosuvastatin is a cholesterol-lowering drug that also attenuates the inflammatory process and oxidative stress via the reduction of superoxide anion production. Superoxide anions are metabolized by manganese-dependent superoxide dismutase (MnSOD or SOD2) in the mitochondria. In humans, there is a gene polymorphism where a change of alanine (Ala) to valine (Val) occurs at the 16th amino acid (Ala16Val-SOD2). The VV genotype has been associated with the risk of developing several metabolic diseases, such as hypercholesterolemia. Thus, to further explore this phenomenon, this study investigated the influence of the Val16Ala-SOD2 polymorphism on the lipid profile and inflammatory and fibrinolytic biomarkers of 122 hypercholesterolemic patients undergoing the first pharmacological cholesterol-lowering therapy who were treated with 20 mg rosuvastatin for 120 days. The findings indicate that the VV patients who present a low-efficiency SOD2 enzyme exhibit an attenuated response to rosuvastatin compared with the A-allele patients. The effect of rosuvastatin on inflammatory and fibrinolytic biomarkers was also less intense in the VV patients. These results suggest some pharmacogenetic effects of Val16Ala-SOD2 in hypercholesterolemia treatment.


Subject(s)
Anti-Inflammatory Agents/therapeutic use , Antioxidants/therapeutic use , Fibrinolysis/drug effects , Fibrinolytic Agents/therapeutic use , Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use , Hypercholesterolemia/drug therapy , Oxidative Stress/drug effects , Pharmacogenomic Variants , Polymorphism, Single Nucleotide , Rosuvastatin Calcium/therapeutic use , Superoxide Dismutase/genetics , Adult , Aged , Biomarkers/blood , Cholesterol/blood , Drug Resistance/genetics , Female , Gene Frequency , Heterozygote , Homozygote , Humans , Hypercholesterolemia/blood , Hypercholesterolemia/enzymology , Hypercholesterolemia/genetics , Inflammation Mediators/blood , Logistic Models , Male , Middle Aged , Multivariate Analysis , Pharmacogenetics , Phenotype , Prospective Studies , Risk Factors , Superoxides/metabolism , Time Factors , Treatment Outcome , Young Adult
5.
Int J Sports Med ; 36(7): 579-84, 2015 Jun.
Article in English | MEDLINE | ID: mdl-25837246

ABSTRACT

In this study we hypothesized that swimming during sensitization phase could result in a preventive effect in mice with allergic asthma. Swiss mice were divided into 4 groups: Control and Swimming (non-sensitized), OVA and OVA+Swimming (sensitized). The allergic inflammation was induced by 2 intraperitoneal injections and 4 aerosol challenges using ovalbumin. Swimming sessions were performed at high intensity over 3 weeks. 48 h after the last challenge mice were euthanized. Swimming decreased OVA-increased total IgE, IL-1, IL-4, IL-5 and IL-6 levels, as well as the number of total cells, lymphocytes and eosinophils in bronchoalveolar lavage fluid, (p<0.05). Simultaneously, swimming also increased IL-10 and glutathione levels in the Swimming and OVA+Swimming groups (p<0.05). The levels of glutathione peroxidase and catalase were increased only in the Swimming group when compared to all groups (p<0.05). 21 days of swimming resulted in an attenuation of pulmonary allergic inflammation followed by an increase of glutathione levels in the OVA group. Swimming only increased the levels of glutathione peroxidase and catalase in non-sensitized mice (p<0.05). These data suggest that the pulmonary anti-inflammatory effects produced by 3 weeks of high-intensity swimming in this model of OVA-induced asthma may be, at least partly, modulated by reduced oxidative stress and increased IL-10 production.


Subject(s)
Asthma/prevention & control , Inflammation/prevention & control , Oxidative Stress/physiology , Swimming/physiology , Animals , Asthma/immunology , Bronchoalveolar Lavage Fluid/immunology , Disease Models, Animal , Glutathione/metabolism , Inflammation/immunology , Interleukin-10/immunology , Male , Mice , Ovalbumin/immunology , Oxidation-Reduction
6.
J Anim Physiol Anim Nutr (Berl) ; 98(3): 446-52, 2014 Jun.
Article in English | MEDLINE | ID: mdl-23751141

ABSTRACT

The aim of this study was to evaluate whether a diet based on palm oil has any influence on the immune response and on the number of eggs per gram of faeces (EPG) of gastrointestinal nematodes (GIN) in dairy sheep. To address this issue, 30 ewes in early lactation were confined and divided into three groups (n = 10) receiving a daily isoproteic and isoenergetic diet. Palm oil was added to the feed at different concentrations: 0% (control; group A), 4% (group B) and 6% (group C). The animals were treated with levamisole 10 days before the beginning of the experiment. Faecal samples were collected and analysed for EPG on day zero of the experiment. On days 60 and 120, individual faecal and blood samples were collected, and the FAMACHA(©) score for assessing clinical anaemia was carried out. The groups receiving palm oil showed a significant reduction in EPG in relation to the control group (A) on day 120. Serum immunoglobulin levels (IgG, IgM and IgE) and proinflammatory cytokine levels (TNF-α, IL-1 and IL-6) were significantly increased on days 60 and 120 (p < 0.05) in groups B and C. Therefore, these results suggest that palm oil stimulates the immune response in sheep, thus reducing EPG of GIN. The hypothesis that palm oil has direct anthelmintic activity should be tested in future studies.


Subject(s)
Animal Feed/analysis , Diet/veterinary , Plant Oils/chemistry , Sheep/immunology , Animal Nutritional Physiological Phenomena , Animals , Anthelmintics/therapeutic use , Dairying , Feces/parasitology , Female , Lactation , Levamisole/therapeutic use , Nematode Infections/drug therapy , Nematode Infections/immunology , Nematode Infections/veterinary , Palm Oil
7.
Genet Mol Res ; 12(4): 5134-44, 2013 Oct 29.
Article in English | MEDLINE | ID: mdl-24301773

ABSTRACT

Environmental contamination by methylmercury (MeHg) is an enormous public health problem in world regions such as Amazonia. MeHg toxic effects seem to be influenced by environmental and genetic factors. However, few studies have evaluated the genetic influences of MeHg toxicity in humans. Therefore, the aim of this study was to evaluate the genetic influence of Ala16Val manganese superoxide dismutase gene polymorphism (Ala16Val-MnSOD) on the cytotoxic effects of in vitro human leukocytes exposed to MeHg. Subjects were selected from 100 individuals aged 26.4 ± 7.3 years genotyped to Ala16Val-MnSOD polymorphism (AA = 6, VV = 6, and AV = 12) to perform in vitro testing using white blood cells (WBCs). Reactive oxygen species production was measured using 2',7'-dichlorofluorescein diacetate fluorimetric assay, and cell viability was measured using MTT assay on WBC samples from the same subjects that were both exposed and not exposed to MeHg (2.5 µM for 6 h). The results showed that AA- and VV-WBCs exposed to MeHg did not display increased reactive oxygen species levels compared to those in cells that were not exposed. However, AV-leukocytes exposed to MeHg displayed increased ROS levels. Cellular viability comparison among genotypes exposed to MeHg showed that the viability of AA-WBCs was lower than that of VV-WBC, with mean values of 3.46 ± 0.13 and 3.08 ± 0.77 (standard error), respectively (P = 0.033), whereas heterozygous cells (AV) displayed intermediate values. This difference was likely due to the higher basal H2O2 production of AA-WBCs compared to that of other genotypes. These results suggest that the Ala16Val-MnSOD polymorphism has toxicogenetic effects in human cells exposed to MeHg.


Subject(s)
Leukocytes/drug effects , Leukocytes/metabolism , Methylmercury Compounds/pharmacology , Polymorphism, Genetic , Superoxide Dismutase/genetics , Alleles , Amino Acid Substitution , Cell Survival/drug effects , Gene Frequency , Genotype , Humans , Reactive Oxygen Species
8.
Res Vet Sci ; 95(2): 389-97, 2013 Oct.
Article in English | MEDLINE | ID: mdl-23706762

ABSTRACT

The aim of this study was to investigate functional and morphological alterations caused by oxidative stress in streptozotocin (STZ)-induced diabetic rats and to evaluate the antioxidant effect of quercetin (QUE) in this disease. One hundred and thirty male Wistar rats, it were randomly distributed in 10 different experimental groups, with ten animals per group: Control Saline (CS), Control Ethanol (CE), Control QUE 5mg/kg (CQ5), Control QUE 25mg/kg (CQ25), Control QUE 50mg/kg (CQ50), Diabetic Saline (DS), Diabetic Ethanol (DE), Diabetic QUE 5mg/kg (DQ5), Diabetic QUE25 mg/kg (DQ25), Diabetic QUE 50mg/kg (DQ50). Therefore, hyperglycemia is directly involved in oxidative stress production, as well as in functional and morphological alterations caused by the excess of free radicals. QUE, specially at the dosage of 50mg/kg, can act as an antioxidant and anti-inflammatory agent, becoming a promising adjuvant in the treatment of diabetes mellitus.


Subject(s)
Anti-Inflammatory Agents/pharmacology , Antioxidants/pharmacology , Diabetes Mellitus, Experimental/pathology , Quercetin/pharmacology , Animals , Catalase/genetics , Catalase/metabolism , Gene Expression Regulation, Enzymologic/physiology , Lipid Peroxidation/drug effects , Male , Rats , Rats, Wistar , Superoxide Dismutase/genetics , Superoxide Dismutase/metabolism
9.
Inhal Toxicol ; 21(11): 906-12, 2009 Sep.
Article in English | MEDLINE | ID: mdl-19459774

ABSTRACT

Cigarette smoke is a complex mixture of various toxic substances that are capable of initiating oxidative damage and promoting blood platelet alterations. In this study, we investigated the activities of the ectoenzymes NTPDase (ectonucleoside triphosphate diphosphohydrolase, CD39) and 5'-nucleotidase (CD73) in platelets as well as adenosine deaminase (ADA) in the plasma of rats exposed to aged and diluted sidestream smoke during 4 weeks. The rats were divided into two groups: I (control) and II (exposed to smoke). After the exposure period, blood was collected and the platelets and plasma were separated for enzymatic assay. The results demonstrated that NTPDase (with ATP as substrate) and 5'-nucleotidase (AMP as substrate) activities were significantly higher in group II (p < 0.05) as compared to group I, while no significant difference was observed for NTPDase with ADP as substrate. The ADA activity was significantly reduced in group II (p < 0.05) as compared with group I. Platelet aggregation was significantly increased in group II (p < 0.05) as compared with group I. We suggest that these alterations in the activity of enzymes from the purinergic system are associated with an increase in platelet aggregation. However, our study has demonstrated that the organism tries to compensate for this enhanced aggregation by increasing hydrolysis of AMP and reducing hydrolysis of adenosine, a potent inhibitor of aggregation and an important modulator of vascular tone.


Subject(s)
Adenosine Deaminase/metabolism , Adenosine Triphosphatases/metabolism , Tobacco Smoke Pollution/adverse effects , 5'-Nucleotidase/blood , Adenosine/blood , Animals , Blood Gas Analysis , Blood Platelets/enzymology , Carboxyhemoglobin/metabolism , Hydrogen-Ion Concentration , Lung/enzymology , Lung/pathology , Male , Platelet Aggregation/drug effects , Pulmonary Fibrosis/chemically induced , Pulmonary Fibrosis/pathology , Rats , Rats, Wistar , Nicotiana/chemistry
SELECTION OF CITATIONS
SEARCH DETAIL
...